Dutch conglomerate Philips has reached a $1.1 billion deal to resolve claims in the United States tied to more than 1 million recalled breathing machines.
The devices were pulled back in 2021 amid concerns they carried a cancer risk for users, and the company has already halted further U.S. sales. The deal resolves injury claims brought by roughly 58,000 people, earmarking a $1.075 billion personal injury settlement and $25 million for medical monitoring.